A detailed history of Orbimed Advisors LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,322,488 shares of RPTX stock, worth $4.49 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
3,322,488
Previous 3,322,488 -0.0%
Holding current value
$4.49 Million
Previous $11 Million 4.24%
% of portfolio
0.27%
Previous 0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$25.71 - $35.24 $2.67 Million - $3.66 Million
-103,837 Reduced 3.03%
3,322,488 $87.2 Million
Q2 2020

Aug 14, 2020

BUY
$30.8 - $32.99 $106 Million - $113 Million
3,426,325 New
3,426,325 $106 Million

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.